Overview
The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are:
- is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups?
- is there any difference in the post-surgical outcomes between intervention and conventional groups?
Participants (intervention) will be provided the immunonutrition supplement before and after operation.
Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.
Description
The clinical trial aims to determine the effectiveness of perioperative IMN intervention on postoperative outcomes among GC patients under Enhanced Recovery after Surgery (ERAS) setting. Patients will prescribed with immunonutrition supplement before and after surgery.
Eligibility
Inclusion Criteria:
- Those who diagnosed with GC
- Candidates for elective operation treatments
Exclusion Criteria:
- Those are involved gastrointestinal tract (complication)
- Those are diagnosed with GC (metastasis)
- Allergy to milk/soy/whey protein
- Participate in other intervention study